Literature DB >> 24676443

Neurofibromatoses: part 1 - diagnosis and differential diagnosis.

Luiz Oswaldo Carneiro Rodrigues1, Pollyanna Barros Batista1, Eny Maria Goloni-Bertollo2, Danielle de Souza-Costa1, Lucas Eliam3, Miguel Eliam4, Karin Soares Gonçalves Cunha5, Luiz Guilherme Darrigo-Junior6, José Roberto Lopes Ferraz-Filho2, Mauro Geller7, Ingrid F Gianordoli-Nascimento1, Luciana Gonçalves Madeira1, Leandro Fernandes Malloy-Diniz1, Hérika Martins Mendes1, Débora Marques de Miranda1, Erika Cristina Pavarino2, Luciana Baptista-Pereira1, Nilton A Rezende1, Luíza de Oliveira Rodrigues1, Carla Menezes da Silva1, Juliana Ferreira de Souza1, Márcio Leandro Ribeiro de Souza1, Aline Stangherlin1, Eugênia Ribeiro Valadares1, Paula Vieira Teixeira Vidigal1.   

Abstract

Neurofibromatoses (NF) are a group of genetic multiple tumor growing predisposition diseases: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH), which have in common the neural origin of tumors and cutaneous signs. They affect nearly 80 thousand of Brazilians. In recent years, the increased scientific knowledge on NF has allowed better clinical management and reduced complication morbidity, resulting in higher quality of life for NF patients. In most cases, neurology, psychiatry, dermatology, clinical geneticists, oncology and internal medicine specialists are able to make the differential diagnosis between NF and other diseases and to identify major NF complications. Nevertheless, due to its great variability in phenotype expression, progressive course, multiple organs involvement and unpredictable natural evolution, NF often requires the support of neurofibromatoses specialists for proper treatment and genetic counseling. This Part 1 offers step-by-step guidelines for NF differential diagnosis. Part 2 will present the NF clinical management.

Entities:  

Mesh:

Year:  2014        PMID: 24676443     DOI: 10.1590/0004-282x20130241

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  8 in total

1.  Evaluation of the dimensions, morphology, and position of the mandibular condyles in individuals with neurofibromatosis 1: a case-control study.

Authors:  Larissa de Oliveira Reis; Rocharles Cavalcante Fontenele; Karina Lopes Devito; Karin Soares Cunha; Andréa de Castro Domingos
Journal:  Clin Oral Investig       Date:  2021-05-29       Impact factor: 3.573

2.  Epidemiological profile and clinical characteristics of 491 Brazilian patients with neurofibromatosis type 1.

Authors:  Luiz Guilherme Darrigo Junior; Victor Evangelista de Faria Ferraz; Marina Candido Visontai Cormedi; Luissa Hikari Hayashi Araujo; Mariana Prado Silva Magalhães; Rafaella Curis Carneiro; Luis Henrique Nunes Sales; Mendel Suchmacher; Karin Soares Cunha; Aguinaldo Bonalumi Filho; David Rubem Azulay; Mauro Geller
Journal:  Brain Behav       Date:  2022-05-04       Impact factor: 3.405

3.  Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas.

Authors:  André Vallejo Da Silva; Fabiana Resende Rodrigues; Mônica Pureza; Vania Gloria Silami Lopes; Karin Soares Cunha
Journal:  BMC Cancer       Date:  2015-03-26       Impact factor: 4.430

4.  Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.

Authors:  Jordan D Frey; Ara A Salibian; Freya R Schnabel; Mihye Choi; Nolan S Karp
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-11-20

5.  Spontaneous pneumothorax as a clinical manifestation of neurofibromatosis type 1.

Authors:  Tine Lorentzen; Hanne Madsen; Marie Josée Zareh Lausten-Thomsen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2021-03-18

6.  Lower fasting blood glucose in neurofibromatosis type 1.

Authors:  Aline Stangherlin Martins; Ann Kristine Jansen; Luiz Oswaldo Carneiro Rodrigues; Camila Maria Matos; Marcio Leandro Ribeiro Souza; Juliana Ferreira de Souza; Maria de Fátima Haueisen Sander Diniz; Sandhi Maria Barreto; Leonardo Mauricio Diniz; Nilton Alves de Rezende; Vincent Michael Riccardi
Journal:  Endocr Connect       Date:  2015-12-02       Impact factor: 3.335

7.  Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1.

Authors:  Sara H Isakson; Anthony E Rizzardi; Alexander W Coutts; Daniel F Carlson; Mark N Kirstein; James Fisher; Jeremie Vitte; Kyle B Williams; G Elizabeth Pluhar; Sonika Dahiya; Brigitte C Widemann; Eva Dombi; Tilat Rizvi; Nancy Ratner; Ludwine Messiaen; Anat O Stemmer-Rachamimov; Scott C Fahrenkrug; David H Gutmann; Marco Giovannini; Christopher L Moertel; David A Largaespada; Adrienne L Watson
Journal:  Commun Biol       Date:  2018-10-02

8.  The challenging management of an assident parotid tumor: a case of solitary plexiform neurofibroma of the parotid facial nerve.

Authors:  Mounir Hmidi; Kaoutar Cherrabi; Mohamed Sinaa; Karim Nadour
Journal:  Braz J Otorhinolaryngol       Date:  2021-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.